{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:57:55Z","timestamp":1778504275949,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Type 2 diabetes mellitus (T2DM) is a progressive condition often necessitating insulin therapy for sustained glycemic control, yet adherence to daily injections remains a significant challenge. While insulin glargine is effective, reducing injection frequency may improve compliance and outcomes. This study evaluates the efficacy and safety of once-weekly insulin icodec compared to once-daily insulin glargine U100.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This systematic review and meta-analysis followed Cochrane and PRISMA guidelines. A comprehensive search across multiple databases identified randomized controlled trials (RCTs) comparing once-weekly insulin icodec with once-daily insulin glargine U100 in adults with T2DM. Eligible studies included adult participants and reported glycemic or safety outcomes. Data synthesis was performed using a random-effects model, with heterogeneity assessed via the I<jats:sup>2<\/jats:sup> statistic.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Five RCTs comprising 2,019 participants met the inclusion criteria. Insulin icodec significantly reduced glycated hemoglobin (MD:\u00a0\u22120.12; 95% CI:\u00a0\u22120.20,\u00a0\u22120.04; <jats:italic toggle=\"yes\">P<\/jats:italic> =\u00a00.003) and increased time in range (TIR; MD: 4.23; 95% CI: 2.20, 6.26; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001) compared to insulin glargine. A modest increase in body weight was observed with insulin icodec, while safety profiles, including hypoglycemia rates and adverse events, were comparable between treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Insulin icodec provides a safe and effective alternative to once-daily insulin glargine for T2DM management, offering similar glycemic control with a once-weekly dosing regimen. The reduced injection burden may enhance adherence and treatment satisfaction, potentially improving long-term disease outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003392","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T10:00:25Z","timestamp":1749549625000},"page":"4452-4466","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Once-weekly insulin icodec vs. daily insulin glargine in type 2 diabetes: a meta-analysis with longitudinal insights"],"prefix":"10.1097","volume":"87","author":[{"given":"Taimoor","family":"Ashraf","sequence":"first","affiliation":[{"name":"Department of Medicine, Nishtar Medical University, Multan, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshy","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Tara","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Memon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areej","family":"Muhammad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muskan","family":"Turesh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ghulam Muhammad Mahar Medical College, Sukkur, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shah","family":"Dev","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ghulam Muhammad Mahar Medical College, Sukkur, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Muhammad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tooba","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow Medical College, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow Medical College, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow Medical College, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simran","family":"Bajaj","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asfia","family":"Qammar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow Medical College, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fnu","family":"Deepak","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aadesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salih Abdella","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hawassa University, Hawassa, Ethiopia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"R1-20250922","doi-asserted-by":"crossref","first-page":"976465","DOI":"10.3389\/fendo.2022.976465","article-title":"Research progress on the mechanism of beta-cell apoptosis in type 2 diabetes mellitus","volume":"13","author":"You","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R2-20250922","doi-asserted-by":"crossref","first-page":"afab231","DOI":"10.1093\/ageing\/afab231","article-title":"Diabetes duration and the risk of dementia: a cohort study based on German health claims data","volume":"51","author":"Reinke","year":"2022","journal-title":"Age Ageing"},{"key":"R3-20250922","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2147\/PPA.S106821","article-title":"Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors","volume":"10","author":"Polonsky","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"R4-20250922","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4093\/dmj.2021.0163","article-title":"A century of progress in diabetes care with insulin: a history of innovations and foundation for the future","volume":"45","author":"Lee","year":"2021","journal-title":"Diabetes Metab J"},{"key":"R5-20250922","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabres.2016.10.003","article-title":"Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: a survey research","volume":"122","author":"Escalada","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"R6-20250922","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diaspect.29.3.166","article-title":"Adherence to insulin therapy","volume":"29","author":"Sarbacker","year":"2016","journal-title":"Diabetes Spectr"},{"key":"R7-20250922","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s13300-018-0421-5","article-title":"Adherence to basal insulin therapy among people with type 2 diabetes: a retrospective cohort study of costs and patient outcomes","volume":"9","author":"Perez-Nieves","year":"2018","journal-title":"Diabetes Ther"},{"key":"R8-20250922","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s12325-018-0819-5","article-title":"Addressing clinical inertia in type 2 diabetes mellitus: a review","volume":"35","author":"Okemah","year":"2018","journal-title":"Adv Ther"},{"key":"R9-20250922","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1503\/cmaj.110779","article-title":"Initiating insulin in patients with type 2 diabetes","volume":"184","author":"Lau","year":"2012","journal-title":"CMAJ"},{"key":"R10-20250922","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s40265-014-0226-4","article-title":"The evolution of insulin glargine and its continuing contribution to diabetes care","volume":"74","author":"Hilgenfeld","year":"2014","journal-title":"Drugs"},{"key":"R11-20250922","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1463-1326.2010.01327.x","article-title":"Patient perspectives on once-weekly medications for diabetes","volume":"13","author":"Polonsky","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"R12-20250922","doi-asserted-by":"crossref","first-page":"e002301","DOI":"10.1136\/bmjdrc-2021-002301","article-title":"Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing","volume":"9","author":"Nishimura","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R13-20250922","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2337\/db20-237-OR","article-title":"237-OR: insulin icodec: an insulin analog suited for once-weekly dosing in type 2 diabetes","volume":"69","author":"H\u00f6velmann","year":"2020","journal-title":"Diabetes"},{"key":"R14-20250922","doi-asserted-by":"crossref","first-page":"A329","DOI":"10.1210\/jendso\/bvab048.672","article-title":"Basal insulin fc (BIF), a novel insulin suited for once weekly dosing for the treatment of patients with diabetes mellitus","volume":"5","author":"Heise","year":"2021","journal-title":"J Endocr Soc"},{"key":"R15-20250922","doi-asserted-by":"crossref","first-page":"e00480","DOI":"10.1002\/edm2.480","article-title":"Clinical outcomes with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-na\u00efve and previously insulin-treated individuals with type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"7","author":"Ahmed","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"key":"R16-20250922","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-20250922","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"R18-20250922","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R19-20250922","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R20-20250922","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R21-20250922","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R22-20250922","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2022474","article-title":"Once-Weekly insulin for type 2 diabetes without previous insulin treatment","volume":"383","author":"Rosenstock","year":"2020","journal-title":"N Engl J Med"},{"key":"R23-20250922","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2337\/dc20-2877","article-title":"Switching to once-weekly insulin icodec versus once-daily insulin glargine u100 in type 2 diabetes inadequately controlled on daily basal insulin: a phase 2 randomized controlled trial","volume":"44","author":"Bajaj","year":"2021","journal-title":"Diabetes Care"},{"key":"R24-20250922","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/dc20-2878","article-title":"A randomized, open-label comparison of once-weekly insulin icodec titration strategies versus once-daily insulin glargine U100","volume":"44","author":"Lingvay","year":"2021","journal-title":"Diabetes Care"},{"key":"R25-20250922","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(23)00520-2","article-title":"Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial","volume":"401","author":"Mathieu","year":"2023","journal-title":"Lancet"},{"key":"R26-20250922","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMoa2303208","article-title":"Weekly icodec versus daily glargine u100 in type 2 diabetes without previous insulin","volume":"389","author":"Rosenstock","year":"2023","journal-title":"N Engl J Med"},{"key":"R28-20250922","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1038\/s41467-024-50477-9","article-title":"Enhanced disulphide bond stability contributes to the once-weekly profile of insulin icodec","volume":"15","author":"Hub\u00e1lek","year":"2024","journal-title":"Nat Commun"},{"key":"R29-20250922","doi-asserted-by":"crossref","first-page":"102615","DOI":"10.1016\/j.dsx.2022.102615","article-title":"Once-weekly basal insulin icodec: looking ONWARDS from pharmacology to clinical trials","volume":"16","author":"Singh","year":"2022","journal-title":"Diabetes Metab Syndr"},{"key":"R30-20250922","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s13300-016-0187-6","article-title":"Lipodystrophy in insulin-treated subjects and other injection-site skin reactions: are we sure everything is clear?","volume":"7","author":"Gentile","year":"2016","journal-title":"Diabetes Ther"},{"key":"R31-20250922","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"R32-20250922","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1111\/dom.15726","article-title":"Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: participant-level meta-analysis of the ONWARDS 1-5 trials","volume":"26","author":"Bajaj","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"R33-20250922","doi-asserted-by":"crossref","first-page":"e000614","DOI":"10.20945\/2359-3997000000614","article-title":"Once-weekly insulin icodec vs. once-daily insulin glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials","volume":"67","author":"Silva","year":"2023","journal-title":"Arch Endocrinol Metab"},{"key":"R34-20250922","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"R35-20250922","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"R36-20250922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MAJ.0b013e31823ea23e","article-title":"Benefits and risks for intensive glycemic control in patients with diabetes mellitus","volume":"343","author":"Blonde","year":"2012","journal-title":"Am J Med Sci"},{"key":"R37-20250922","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","article-title":"Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study","volume":"28","author":"Peyrot","year":"2005","journal-title":"Diabetes Care"},{"key":"R38-20250922","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2013.06.010","article-title":"Initiating basal insulin therapy in type 2 diabetes: practical steps to optimize glycemic control","volume":"126","author":"Philis-Tsimikas","year":"2013","journal-title":"Am J Med"},{"key":"R39-20250922","doi-asserted-by":"crossref","first-page":"bvad177","DOI":"10.1210\/jendso\/bvad177","article-title":"Once-weekly insulin icodec versus once-daily long-acting insulin for type II diabetes: a meta-analysis of randomized controlled trials","volume":"8","author":"Abuelazm","year":"2024","journal-title":"J Endocr Soc"},{"key":"R40-20250922","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0140-6736(23)02179-7","article-title":"Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial","volume":"402","author":"Russell-Jones","year":"2023","journal-title":"Lancet"},{"key":"R41-20250922","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eprac.2023.11.004","article-title":"Once-weekly insulin icodec as compared to once-daily basal insulins: a meta-analysis","volume":"30","author":"Mukhopadhyay","year":"2024","journal-title":"Endocr Pract"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T07:00:33Z","timestamp":1758524433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003392","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"2024-12-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}